TY  - JOUR
AU  - Messas, Nathan
AU  - Tanguay, Jean-François
AU  - Lordkipanidzé, Marie
PY  - 2017
TI  - Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial
JF  - Journal of Thoracic Disease; Vol 9, No 5 (May 28, 2017): Journal of Thoracic Disease
Y2  - 2017
KW  - 
N2  - The recently reported ANTARCTIC trial by Cayla and colleagues is the latest large-scale study of personalized antiplatelet therapy based on platelet function testing (1). In this open-label, blinded end-point, randomized, controlled trial, the authors ascertained the net clinical benefit of individualized antiplatelet therapy based on platelet function monitoring in elderly patients undergoing stenting (PCI) for an acute coronary syndrome (ACS).
UR  - https://jtd.amegroups.org/article/view/13294